The most comprehensive international comparison of cancer survival to date, covering countries that are home to two-thirds of the world’s population, shows extremely wide differences in survival between countries.
The CONCORD-2 study, published in The Lancet, reports 5-year survival estimates for 25.7 million cancer patients diagnosed with one of 10 common cancers and 75,000 children diagnosed with acute lymphoblastic leukaemia between 1995 and 2009, using individual patient data from 279 cancer registries in 67 countries, including Ireland. Even after researchers had adjusted for differences between countries and regions in the risk of death from other causes by age, sex, and race, and over time, they found very large variations between countries in survival for specific cancers.
on Wed, 26/11/2014 - 09:56 by moconnor